SS Innovations International (NASDAQ: SSII) announced that its subsidiary, the SS International Centre for Robotics Surgery (SSICRS), has graduated the inaugural class of its Cardiac Robotic Surgery Training program. The five-day course brought together 33 participants from seven countries and 16 international faculty members for classroom instruction, live surgical demonstrations, and hands-on training using the company’s SSi Mantra surgical robotic system.
The graduation marks a milestone for SS Innovations as it seeks to make robotic surgery more affordable and accessible worldwide. The training program is part of a broader strategy to support the adoption of robotic-assisted surgery by educating surgeons from diverse regions. SSICRS plans to expand its educational offerings through additional condensed training programs covering multiple surgical specialties, including urology, gynecology, thoracic, colorectal, gastrointestinal, and general surgery.
According to the company, the training center combines modern lecture facilities, advanced simulation labs, tele-proctoring, and online learning modules to support surgeon education. This integrated approach aims to lower the barriers to adopting robotic surgery, particularly in underserved markets. The SSi Mantra system, developed by SS Innovations, is designed to be user-friendly and cost-effective, potentially enabling more hospitals to offer robotic procedures.
The importance of this announcement lies in its potential impact on global healthcare access. Robotic surgery offers benefits such as reduced recovery times, less pain, and lower complication rates compared to traditional open surgery. However, high costs and limited training opportunities have restricted its use to wealthy countries and large medical centers. By training surgeons from seven countries—including likely emerging markets—SS Innovations is addressing a critical bottleneck: the shortage of skilled robotic surgeons.
For the industry, this development signals a shift toward democratizing robotic surgery. Competitors like Intuitive Surgical have long dominated the market with higher-priced systems, but SS Innovations aims to compete on affordability. If successful, their approach could pressure prices down and accelerate global adoption. For patients, this means greater access to minimally invasive procedures, potentially improving outcomes for cardiac conditions and other diseases.
SS Innovations International, an American company headquartered in India, plans to expand the global presence of its surgical robotic solutions. The company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support various procedures including cardiac surgery. The company’s vision is to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population.
For more details, the full press release is available at https://ibn.fm/7oFgo. Forward-looking statements in this article involve risks and uncertainties as detailed in the company’s SEC filings. Readers are advised to review the full terms of use and disclaimers on the InvestorBrandNetwork website at http://IBN.fm/Disclaimer.
